EMIS Group plc, through its subsidiaries, provides healthcare software, information technology, and related services for healthcare professionals in the United Kingdom. It operates in four segments: Primary, Community & Acute Care; Community Pharmacy; Specialist & Care; and Patient. The company offers clinical management systems that hold patient records for healthcare providers and commissioners; dispensary pharmacy management software for the community pharmacy market; and Egton non-clinical software for health and social care. It also provides diabetic screening services under the EMIS Care brand; and diabetic eye screening software and other ophthalmology-related solutions, as well as operates Patient.info, a patient self-care information Website. The company was founded in 1987 and is headquartered in Leeds, the United Kingdom.
Industry, Sector and Symbol
Industry Technical & System Software
Sub-IndustryN/A
SectorComputer and Technology
Phone+44-113-3803000
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
Employees2,046
OptionableNot Optionable
Emis Group (LON:EMIS) Frequently Asked Questions
What is Emis Group's stock symbol?
Emis Group trades on the London Stock Exchange (LON) under the ticker symbol "EMIS."
How often does Emis Group pay dividends? What is the dividend yield for Emis Group?
Emis Group declared a dividend on Friday, August 31st. Shareholders of record on Thursday, September 27th will be paid a dividend of GBX 14.20 per share on Friday, November 2nd. This represents a yield of 1.47%. The ex-dividend date of this dividend is Thursday, September 27th. This is a boost from Emis Group's previous dividend of $12.90. The official announcement can be viewed at this link. View Emis Group's Dividend History.
How were Emis Group's earnings last quarter?
Emis Group Plc (LON:EMIS) posted its quarterly earnings data on Wednesday, March, 14th. The company reported $47.20 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $46.30 by $0.90. The firm had revenue of $160.35 million for the quarter. View Emis Group's Earnings History.
What price target have analysts set for EMIS?
1 brokerages have issued 1 year price targets for Emis Group's stock. Their forecasts range from GBX 1,160 to GBX 1,160. On average, they anticipate Emis Group's share price to reach GBX 1,160 in the next year. This suggests a possible upside of 26.8% from the stock's current price. View Analyst Price Targets for Emis Group.
What is the consensus analysts' recommendation for Emis Group?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Emis Group in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Emis Group.
Has Emis Group been receiving favorable news coverage?
News stories about EMIS stock have trended neutral this week, according to InfoTrie. The research firm identifies positive and negative press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Emis Group earned a news impact score of 0.1 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 4.0 out of 10, meaning that recent press coverage is somewhat unlikely to have an impact on the company's share price in the near future.
Who are some of Emis Group's key competitors?
Some companies that are related to Emis Group include 99 Wuxian (NNW), Absolute Software (ABT), Artilium (ARTA), Aurinia Pharmaceuticals (AUP), Computer Modelling Group (CMG), Covata (CVT), Dotdigital Group (DOTD), Eckoh (ECK), Electronic Data Processing (EDP), Escher Group (ESCH), EU supply (EUSP), GB Group (GBG), Gresham Technologies (GHT), Ideagen (IDEA) and IDOX (IDOX).
Who are Emis Group's key executives?
Emis Group's management team includes the folowing people:
- Mr. Andrew John Thorburn, CEO & Exec. Director (Age 57)
- Mr. Peter J. Southby, CFO & Exec. Director (Age 46)
- Mr. Pete Malcolm, Group Chief Technology Officer
- Ms. Jacqui Summons, People Director
- Dr. Shaun O'Hanlon, Chief Medical Officer (Age 54)
How do I buy shares of Emis Group?
Shares of EMIS and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Emis Group's stock price today?
One share of EMIS stock can currently be purchased for approximately GBX 915.
What is Emis Group's official website?
How can I contact Emis Group?
Emis Group's mailing address is Rawdon House, Green Lane, LEEDS, LS19 7BY, United Kingdom. The company can be reached via phone at +44-113-3803000.
MarketBeat Community Rating for Emis Group (LON EMIS)
MarketBeat's community ratings are surveys of what our community members think about Emis Group and other stocks. Vote "Outperform" if you believe EMIS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EMIS will underperform the S&P 500 over the long term. You may vote once every thirty days.
